Lawmakers Dismiss McKinsey’s Apology on Opioid Crisis as ‘Empty’
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
View original article
Contributor: Michael Forsythe, Walt Bogdanich and Chris Hamby
